AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. An NDA for DSUVIA™ (sufentanil sublingual tablet, 30 mcg) with a proposed indication for the treatment of moderate-to-severe acute pain in medically supervised settings has been submitted.